| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Education by peers is the key to success
|
Galindo, Larry
|
|
2007
|
18 |
5 |
p. 411-416
6 p.
|
artikel
|
| 2 |
Everybody's got it, but…: Situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada
|
Wozniak, Lisa
|
|
2007
|
18 |
5 |
p. 388-396
9 p.
|
artikel
|
| 3 |
Global estimates of prevalence of HCV infection among injecting drug users
|
Aceijas, Carmen
|
|
2007
|
18 |
5 |
p. 352-358
7 p.
|
artikel
|
| 4 |
HCV Synthesis Project: Preliminary analyses of HCV prevalence in relation to age and duration of injection
|
Hagan, Holly
|
|
2007
|
18 |
5 |
p. 341-351
11 p.
|
artikel
|
| 5 |
Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montréal
|
Roy, Élise
|
|
2007
|
18 |
5 |
p. 397-405
9 p.
|
artikel
|
| 6 |
Hepatitis C prevention and care for injecting drug users
|
Friedman, Samuel R.
|
|
2007
|
18 |
5 |
p. 333-334
2 p.
|
artikel
|
| 7 |
Hepatitis C prevention and true harm reduction
|
Madden, Annie
|
|
2007
|
18 |
5 |
p. 335-337
3 p.
|
artikel
|
| 8 |
HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management
|
Lazarus, Jeffrey V.
|
|
2007
|
18 |
5 |
p. 426-432
7 p.
|
artikel
|
| 9 |
How can hepatitis C be prevented in the long term?
|
Mateu-Gelabert, Pedro
|
|
2007
|
18 |
5 |
p. 338-340
3 p.
|
artikel
|
| 10 |
Improving access to HCV treatment: External jugular venepuncture can overcome problems with difficult venous access
|
Mason, Susan
|
|
2007
|
18 |
5 |
p. 433-436
4 p.
|
artikel
|
| 11 |
Integrating HCV services for drug users: A model to improve engagement and outcomes
|
Sylvestre, Diana L.
|
|
2007
|
18 |
5 |
p. 406-410
5 p.
|
artikel
|
| 12 |
Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: A comprehensive approach
|
Birkhead, Guthrie S.
|
|
2007
|
18 |
5 |
p. 417-425
9 p.
|
artikel
|
| 13 |
Prejudice among health care workers toward injecting drug users with hepatitis C: Does greater contact lead to less prejudice?
|
Brener, Loren
|
|
2007
|
18 |
5 |
p. 381-387
7 p.
|
artikel
|
| 14 |
Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran
|
Zamani, Saman
|
|
2007
|
18 |
5 |
p. 359-363
5 p.
|
artikel
|
| 15 |
Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: Insights from the ATAHC study
|
Nguyen, Oanh K.
|
|
2007
|
18 |
5 |
p. 447-451
5 p.
|
artikel
|
| 16 |
The depiction of stigmatization in research about hepatitis C
|
Paterson, Barbara L.
|
|
2007
|
18 |
5 |
p. 364-373
10 p.
|
artikel
|
| 17 |
The drugs that dare not speak their name: Injecting and other illicit drug use during treatment for hepatitis C infection
|
Hopwood, Max
|
|
2007
|
18 |
5 |
p. 374-380
7 p.
|
artikel
|
| 18 |
The Jailbreak Health Project – incorporating a unique radio programme for prisoners
|
Minc, Ariane
|
|
2007
|
18 |
5 |
p. 444-446
3 p.
|
artikel
|
| 19 |
Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection
|
Grebely, Jason
|
|
2007
|
18 |
5 |
p. 437-443
7 p.
|
artikel
|
Tijdschrift beschrijving